-
29sPart 1 | Session 2 Johannes Brachmann
-
1m 25sPart 2 | Session 1 Atul Verma
-
44sPart 2 | Session 2 Johannes Brachmann
-
1m 22sPart 3 | Session 1 Atul Verma
-
45sPart 3 | Session 2 Johannes Brachmann
-
59sPart 4 | Session 1 Atul Verma
-
51sPart 4 | Session 2 Johannes Brachmann
-
1m 10sPart 5 | Session 1 Atul Verma
-
1m 9sPart 5 | Session 2 Johannes Brachmann
-
1m 10sPart 6 | Session 1 Atul Verma
-
43sPart 6 | Session 2 Johannes Brachmann
-
50sPart 7 | Session 1 Atul Verma
-
1m 14sPart 7 | Session 2 Johannes Brachmann
Key opinion leaders discuss their thoughts on the CABANA Trial in a series of 60-second videos. Get their views in under 1 minute!
More from this programme
Part 1
Are further studies needed?
| 2 sessions | |
| Atul Verma | Watch now |
| Johannes Brachmann | Watch now |
Part 2
How will CABANA change your practice?
| 2 sessions | |
| Atul Verma | Watch now |
| Johannes Brachmann | Watch now |
Part 3
What was the biggest weakness of CABANA?
| 2 sessions | |
| Atul Verma | Watch now |
| Johannes Brachmann | Watch now |
Part 4
What was the biggest strength of CABANA?
| 2 sessions | |
| Atul Verma | Watch now |
| Johannes Brachmann | Watch now |
Part 5
Why do you think CABANA misses its primary endpoint?
| 2 sessions | |
| Atul Verma | Watch now |
| Johannes Brachmann | Watch now |
Part 6
Should we stop catheter ablation after CABANA?
| 2 sessions | |
| Atul Verma | Watch now |
| Johannes Brachmann | Watch now |
Part 7
Can you describe CABANA in your own words?
| 2 sessions | |
| Atul Verma | Watch now |
| Johannes Brachmann | Watch now |
Faculty Biographies
Atul Verma
Director of Cardiology
Dr Atul Verma is currently Director of Cardiology at the McGill University Health Centre & McGill University, Montreal, CA.
Specialising in complex arrhythmias like atrial fibrillation and ventricular tachycardia, he has published over 300 peer-reviewed articles including in The New England Journal of Medicine. Dr Verma has co-chaired the Canadian Cardiovascular Society Atrial Fibrillation Guidelines Committee and contributed to the HRS/EHRA Consensus Document on Catheter Ablation of Atrial Fibrillation. He currently leads and participates in multiple international clinical trials.